Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review
- 5 January 2011
- journal article
- review article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 30 (2) , 165-171
Abstract
Over the last few years, several studies in patients with systemic lupus erythematosus (SLE) have demonstrated an association between valvulopathy, including Libman–Sacks endocarditis (LS) and the presence of antiphospholipid antibodies (aPL), suggesting a role of these antibodies in the pathogenesis of the lesions. On the other hand, other studies found no such association. The aim of the present study is to analyze, by means of a systematic review, the existent evidences about the association between aPL and valvular lesions, including LS endocarditis, in patients with SLE. The information was obtained through searches for articles in the MEDLINE (1966 to 2010), SciELO, and LILACS databases, using the following key words: “Libman–Sacks endocarditis”, “antiphospholipid and Libman–Sacks”, “antiphospholipid and valvular heart disease”, “antiphospholipid and verrucous endocarditis”, “antiphospholipid and heart”, “antiphospholipid and valvular vegetations”, “anticardiolipin antibodies” and the corresponding translations in Portuguese. Twenty articles were found, which evaluated the association between the presence of aPL and valvulopathy. Thirteen of these studies evaluated the association of aPL with the LS lesion. Of the 20 articles, 15 demonstrated a positive association between aPL and valvular lesions, whereas 5 articles demonstrated that there was no association. Evidence of an association between the presence of aPL and valvular lesion was demonstrated in the majority of studies. Nevertheless, the possible role of these antibodies in the etiopathogenesis of the lesion has not yet been proved.Keywords
This publication has 42 references indexed in Scilit:
- Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literatureJournal of Cardiothoracic Surgery, 2010
- Establishing the Diagnosis of Libman–Sacks Endocarditis in Systemic Lupus ErythematosusJournal of General Internal Medicine, 2008
- Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupusRheumatology, 2006
- Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodiesInternational Journal of Cardiology, 1995
- A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosusAmerican Heart Journal, 1993
- Cardiovascular Disease in Systemic Lupus Erythematosus A Study of 75 Patients from a Defined PopulationMedicine, 1992
- Cardiac involvement in systemic lupus erythematosus detected by echocardiographyThe American Journal of Cardiology, 1990
- Antiphospholipid antibodies, valvular h eart disease, and systemic lupus erythematosusThe American Journal of Medicine, 1989
- Prevalence, Morphologic Types, and Evolution of Cardiac Valvular Disease in Systemic Lupus ErythematosusNew England Journal of Medicine, 1988
- Transesophageal Echocardiography: Technique, Anatomic Correlations, Implementation, and Clinical ApplicationsMayo Clinic Proceedings, 1988